Charles Legg
Direttore operativo presso CureLab Oncology, Inc.
Posizioni attive di Charles Legg
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
CureLab Oncology, Inc.
 CureLab Oncology, Inc. BiotechnologyHealth Technology Part of Curelab Veterinary, Inc., CureLab Oncology, Inc. is a pre-IPO, clinical-stage biotech company headquartered in the greater area. The company is based in Boston, MA. The company is dedicated to advancing new and safer therapeutics for solid tumors and other oncology and inflammatory indications. CureLab Oncology is developing an experimental DNA therapy called p62/sqstm1, which consists of a circular piece of DNA called a plasmid that includes a gene for a human protein. The company was founded by Alexander Shneider, who has been the CEO since incorporation. | Direttore operativo | - | - |
ZEA Biosciences Corp.
 ZEA Biosciences Corp. Agricultural Commodities/MillingProcess Industries Zea Biosciences Corp. engages in agriculture banking and financial services. The company was founded in 2018 and is headquartered in Walpole, MA. | Direttore operativo | - | - |
| Secular Student Alliance | Direttore/Membro del Consiglio | 01/01/2021 | - |
Storia della carriera di Charles Legg
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
Posizioni
| Chief Operating Officer | 2 |
| Director/Board Member | 1 |
Settori
| Process Industries | 2 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 3 |
|---|---|
ZEA Biosciences Corp.
ZEA Biosciences Corp. Agricultural Commodities/MillingProcess Industries Zea Biosciences Corp. engages in agriculture banking and financial services. The company was founded in 2018 and is headquartered in Walpole, MA. | Process Industries |
CureLab Oncology, Inc.
CureLab Oncology, Inc. BiotechnologyHealth Technology Part of Curelab Veterinary, Inc., CureLab Oncology, Inc. is a pre-IPO, clinical-stage biotech company headquartered in the greater area. The company is based in Boston, MA. The company is dedicated to advancing new and safer therapeutics for solid tumors and other oncology and inflammatory indications. CureLab Oncology is developing an experimental DNA therapy called p62/sqstm1, which consists of a circular piece of DNA called a plasmid that includes a gene for a human protein. The company was founded by Alexander Shneider, who has been the CEO since incorporation. | Health Technology |
| Secular Student Alliance |
- Borsa valori
- Insiders
- Charles Legg
- Esperienza
